The proportion of patients who experienced at least one or more adverse events was higher in the iron dextran arm compared with the iron sucrose arm 9/33 (27.3%) versus 5/34 (14.7%); however, this did not reach statistical significance (P = 0.21).
← all excerpts
Comparison of intravenous low molecular weight iron dextran and intravenous iron sucrose for the correction of anaemia in pre-dialysis chronic kidney disease patients: a randomized single-centre study in Nigeria.
1
0.2100
0.2100